Clinical Trial

Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated May 7, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
Prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial of efficacy and safety with subcutaneous immunotherapy in patients with mild to moderate rhinitis / rhinoconjunctivitis with or without mild to moderate asthma sensitized to grasses and olive
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-05-17; most recent amendment 2025-05-05.
Status change: Not Yet Recruiting → Recruiting 2021-08-13
Trial Details
NCT Number NCT04891237
Lead Sponsor Inmunotek S.L.
Conditions Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic
Enrollment 180 participants
Start Date 2021-06-14
Primary Completion 2026-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-07